FARXIGA, also known by its generic name dapagliflozin, is a prescription medication used primarily in the treatment of type 2 diabetes. It belongs to a class of drugs known as sodium-glucose cotransporter 2 (SGLT2) inhibitors, which work by helping the kidneys remove glucose from the bloodstream through the urine, thereby lowering blood sugar levels. In addition to its use in managing diabetes, FARXIGA is also approved for the treatment of heart failure in adults with reduced ejection fraction, regardless of their diabetes status. By improving blood sugar control and offering cardiovascular benefits, FARXIGA plays a crucial role in the comprehensive management of patients with type 2 diabetes and heart failure. However, like all medications, it may have side effects and is not suitable for everyone, including patients with severe renal impairment or those on dialysis, so it's important to use it under the guidance of a healthcare professional.